Evidence Hub

Targeted And Controlled Drug Delivery Approaches In The Management Of Gastroesophageal Reflux Disease

Kavya Chauhan, Saumya Das, Avijit Mazumder, MVNL Chaitanya

International Journal of Drug Delivery Technology, 2026

Abstract

Gastroesophageal reflux disease (GERD) is a chronic gastroenterological disorder resulting from the backward flow of gastric contents into the esophagus, clinical manifestations of which may include heartburn and regurgitation, with complications including erosive esophagitis and Barrett’s esophagus. While proton pump inhibitors (PPIs) are broadly used as first-line, limitations around incomplete symptom relief and long-term dependence illustrate the need for better treatment strategies. Controlled delivery systems for targeted drugs are a novel approach to increase drug stability and long-term gastric residence time, site-specific action, and prolong therapeutic effects of the system. It has been established that various systems including mucoadhesive formulations, pH-responsive carriers, raft-forming systems, gastroretentive drug delivery systems and nanotechnology-based carriers, are able to achieve higher bioavailability on GERD management which leads to therapeutic efficacy enhancement and patient compliance improvement.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free